All protocols
Immune / Anti-Inflammatory

Vilon Peptide Protocol & Dosing

Updated 2mo ago 5 min read 137+ helpful Calculator
Validity Score

Validity Score

17 Speculative
Evidence 20
Community 35
Completeness 71
Actionability 80
Coverage 100
Penalty -26

This score combines formal evidence, page completeness, calculator readiness, and community convergence.

What it is

Vilon is a short peptide bioregulator from the Khavinson literature.

Evidence boundary

Regional literature only. Not a validated standard.

Trial evidence

  • PMID 37782636 — [KE peptide regulates SIRT1, PARP1, PARP2 gene expression and protein synthesis in human mesenchymal stem cells aging.].
  • PMID 37042594 — EPIGENETIC MODIFICATION UNDER THE INFLUENCE OF PEPTIDE BIOREGULATORS ON THE “OLD” CHROMATIN.
  • PMID 35408963 — Peptides Regulating Proliferative Activity and Inflammatory Pathways in the Monocyte/Macrophage THP-1 Cell Line.
  • PMID 33342107 — [The influence of AEDG and KE peptides on mitochondries stain and L7A ribosomes protein expression during human pineal gland and thymus cell senescence in vitro.].

Preparation and measurement

Reconstitution: 20 mg vial + 3 mL BAC = 6.67 mg/mL.

Concentration matches.

Reference schedule

Reference schedule
PhaseDoseDraw / measureFrequencyWeekly total
Days 1–20 (cycle on)500 mcg7.5 U (0.075 mL)Once daily during cycle (20 days on / 4–6 months off)3.5 mg/week
Months 1–6 (cycle off)0 mcg0 U (no draw)Off0

Days 1–20 (cycle on)

Dose
500 mcg
Draw / measure
7.5 U (0.075 mL)
Frequency
Once daily during cycle (20 days on / 4–6 months off)
Weekly total
3.5 mg/week

Months 1–6 (cycle off)

Dose
0 mcg
Draw / measure
0 U (no draw)
Frequency
Off
Weekly total
0

Weekly totals apply only during the active phase.

Titration rules

  • Days 1–20 (cycle on): 500 mcg/day. Once daily during the 20-day active phase.

  • Cycle structure: 20-day active phase, 4–6 month rest. 1–2 cycles per year is standard.

  • Timing: Once daily during active phase; time of day flexible. Rotate injection sites.

  • Immune modulation claims in the literature

  • Tolerability

  • Injection-site reactions

Practical rules

  • Rotate sites only if any injection note is being reviewed.
Was this protocol helpful?
Share via
Supply & lot verification Availability and batch-linked COA records for Vilon Peptide Protocol & Dosing are tracked with the current supplier listings. View availability & COA →

Dosing Calculator

10 mg + 2 mL BAC · week 1 500 mcg
LIVE CALCULATIONvolume / concentration / draw
RP–CALC–01
DRAW AMOUNT10 units0.1 mL · U-100
Draw 10 units, equivalent to 0.1 milliliters.
Concentration5 mg/mL
Selected dose0.5 mg (500 mcg) = 10 units
Enter a desired amount in milligrams or micrograms.
05 Standard amounts
1–10 mg · 0.5 mg steps
06 Suggested doses Select a row
1 unit = 0.01 mL on a U-100 syringe. Values retain decimal precision; visual marks are not silently snapped.
07 cycle summary

Vials required for Cycle

Estimate how much material you need for a full cycle, including cycle length and the number of cycles you plan to run.

Cycle total —
Total required vials —
Total reconstitution —
Total BAC water —
08 projected levels

How the draws stack up

A first-order model of depot absorption and elimination, run on the draws and cadence above. Pick the half-life from whatever your own source documents — this page does not assume one per compound. A planning sketch — not a prediction for any compound or any individual.

Half-life

Modelled level across the cycle. Each spike is one draw.

Accumulation—steady state vs one draw
Peak-to-trough—inside one interval
Steady state—about 4 half-lives
Draws modelled—at this cadence
Vial yieldat the selected amount
Draws per vial—
Lasts—
Volume used—
Limiting factor—
Water matrixsame vial, same amount
WaterStrengthDraw
0.5 mL——
1 mL——
2 mL——
3 mL——
5 mL——

Research Protocols

Keep up to date with latest protocols, updates and offers

An occasional email when a new protocol lands or an existing one is revised. No more than once a month.